INTRODUCTION
In the recent years, many exciting discoveries regarding the genomics of gastric cancer have been made, but it remains a major health problem as a result of the population growth, ageing, high mortality and poor prognosis for this disease (1) (2) (3) . The incidence of gastric cancer varies considerably according to age, gender, socioeconomic conditions and ethnicity, and despite some of the highest risk populations are in Asian countries such as Japan, Korea and China, other Asian countries present relatively low rates (4) (5) (6) . To date, the etiology of gastric cancer is still not fully understood (7) . It is well known that environmental factors such as dietary habits, Helicobacter pylori (H. pylori) infection, tobacco smoking, and alcohol consumption are more important than genetics in the development and progression of gastric cancer (1) (2) (3) 8) . However, only 1%-5% of individuals with the bacteria actually develop gastric cancer and the pathogenesis is dependent on bacterial strain virulence, host genetic susceptibility and environmental factors (9) . Among human cancers, gastric carcinogenesis appears
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polymorphism with susceptibility to gastric cancer: meta-analysis of 6,101 cases and 8,557 controls to be a complex multistep processes. Diverse array of genetics factors including functional polymorphisms, chromosomal instability, microsatellite instability, promoter methylation, and abnormal microRNA expression play important roles in gastric cancer carcinogenesis (10) . Interleukin-10 (IL-10) is an important immunoregulatory cytokine which plays a key role in controlling the balance between cellular and humoral immune responses (11) . Previous studies have presented evidence that IL-10 may inhibit tumor development and progression (12) . It has been reported that the -1082 A/G polymorphism at promoter region of the IL-10 gene may influence this cytokine production and to be associated with the risk of different malignancies including cervical cancer (13) , esophageal cancer, nasopharyngeal cancer, oral cancer (14) , colon cancer (15) , and hepatocellular carcinoma (16) . However, the precise mechanism by which the between IL-10 polymorphisms may modulate cancer progression remains unknown (11, 12) . Over the past 2 decades, several epidemiological studies have reported the role of IL-10 -1082 A/G (rs1800896) polymorphism in gastric cancer development (17) . However, the results were inconsistent rather than conclusive, as result of the small sample size in the most of studies. While meta-analysis is considered a powerful tool for combining data from all eligible studies with more statistical power and obtaining precise estimates. Therefore, we conducted a meta-analysis of all available case-control studies to derive a more precise estimation of the association between of IL-10 -1082 A/G (rs1800896) polymorphism and gastric cancer risk. In addition, current meta-analysis analyzed available data to explore any role of ethnicity and studies quality on the association of IL-10 -1082 A/G (rs1800896) polymorphism in gastric cancer risk.
METHODS

Study identification and selection
A systematic literature search was performed for the relevant available studies published in PubMed, Web of Science, Chinese Biomedical Literature database, China National Knowledge Infrastructure database and google scholar up to August 1, 2017. The search strategy identified the eligible studies using the following keywords: ''Interleukin-10'', ''IL-10'', ''-1082 A/G'', ''rs1800896'', ''polymorphism'', ''genotype'', ''variant'', ''mutation'', ''gastric cancer'', and ''stomach cancer''. Additionally, the reference lists of retrieved studies, review articles, clinical trials and previous meta-analyses, were manually searched for collecting more relevant studies that was missed in the electronic search.
Eligibility criteria
The following inclusion criteria were used in selecting literature for meta-analysis: (a) evaluation of the association between IL-10 -1082 A/G (rs1800896) polymorphism and gastric cancer; (b) studies with case-control or cohort design; (c) sufficient published data for calculating odds ratios (ORs) with their 95% confidence intervals (95% CIs); and (d) publications in English and Chinese. If multiple studies from the same data were available, only the most recent, larger sample size or complete study was selected. The studies were excluded (a) only abstracts, review articles, case reports, letter to editors or editorials; (b) not designed as case-control or cohort studies; (c) not offering essential data; (d) control group not including healthy induvial; (e) duplicate of previous published articles.
Data extraction and quality assessment
The following data of eligible studies were collected by two investigators independently if available: first author, year of publication, country origin, ethnicity, total number of cases and controls, the frequencies of genotypes, genotyping technique, minor allele frequencies (MAFs), P-value for Hardy-Weinberg equilibrium (HWE). In case of disagreement, consensus was obtained by discussion, or a third author would assess these articles. The quality of selected studies was tested by the confirmation of HWE in control groups, and studies without the confirmation of HWE in controls were defined as low-quality studies, while studies with the confirmation of HWE in controls were defined as high-quality studies.
Statistical analysis
The strength of the association between the IL-10 -1082 A/G (rs1800896) polymorphism and gastric cancer risk was measured by crude odds ratios (ORs) with 95% confidence intervals (CIs).
Pooled estimates of the OR were obtained by calculating a weighted average of OR from each study. The statistical significance of the pooled OR was determined using the Z-test. The meta-analysis examined the IL-10 -1082 A/G (rs1800896) polymorphism association under the allele model (G vs A), the homozygote model (GG vs AA), homozygote model (GA vs AA), heterozygote model and (GA vs AA), dominant model (GG+GA vs AA), and recessive model (GG vs GA+AA). The Q-statistic and the I 2 -statistic were used to assess the heterogeneity between studies in the meta-analysis. I 2 was a value describe the degree of heterogeneity between studies, where 0-25% indicated no observed heterogeneity and larger values showed increasing heterogeneity, with 25%-50% regarded as low, 50%-75% as moderate, and 75%-100% as high (18, 19) . A P-value greater than 0.10 for the Q-statistic indicates a lack of heterogeneity between studies, so the pooled OR estimate of the included studies was calculated by the fixed-effects model (MantelHaenszel method) (20) . Otherwise, the random-effects model (the DerSimonian and Laird method) was used (21) . The heterogeneity between studies was adjusted by subgroup analysis, HWE status and meta-regression. Departure from Hardy-Weinberg equilibrium (HWE) in controls was tested by the chi-square test, and a P-value <0.05 was considered significant. One-way sensitivity analyses were performed to assess the stability of the results, namely, a single study in the meta-analysis was deleted each time to reflect the influence of the individual dataset on the pooled OR. Funnel plots and Egger's linear regression test were used to provide diagnosis of the potential publication bias (22, 23) . To ensure reliability and accuracy of the results, two investigators entered the data into the software independently and reached a consensus. All statistical analyses were performed by using Comprehensive Meta-Analysis software version 2.20 (Stata Corp., College Station, TX, USA). All the P values were two-sided, and a P value less than 0.05 was considered statistically significant.
RESULTS
Based on the search criteria and manual search of references cited in the published case-control studies and meta-analyses, 67 individual articles were found. After screening the titles and abstracts, 29 articles were excluded because they were not relevant to the association of IL-10 -1082 A/G polymorphism with risk of gastric cancer. After reading the full texts of the remaining 37 articles, we found one article had not sufficient data of genotype for calculating OR and 95% CI, four articles were meta-analyses, and two articles were reviews. Finally, a total of 30 studies (4) (5) (6) (7) (10) (11) (12) (13) (14) (16) (17) (18) (19) (20) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) published from 2002 and 2015 with 6,101 cases and 8,557 controls met our inclusion criteria. The main characteristics of these studies were listed in TABLE 1. Among the 31 case-control studies, there were 21 studies of Asians (24) (25) (26) (27) (28) (29) (30) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) , six studies of Caucasians (47) (48) (49) (50) (51) (52) , and three studies of Latinos (53, 54, 32) descendants. The countries of these studies included China, Korea, Japan, Taiwan, India, USA, Italy, Finland, Spain, Romania, Costa Rica, Honduras and Chile. All the genotype distributions of controls were in agreement with HWE for IL-10 -1082 A/G polymorphism except for eleven studies (27, 29, 30, 34, 38, 41, 42, (45) (46) (47) 49) . Twenty of 31 studies were in accordance with HWE and were therefore defined as high-quality studies (TABLE 1) .
Quantitative data synthesis
The main results of this meta-analysis were listed in 
Test of heterogeneity and sensitivity analysis
The heterogeneity test showed that there was significant between-study heterogeneity in terms of the IL-10 -1082 A/G polymorphism in all five genetic models (TABLE 2) . Then, we used a meta-regression analysis to explore the source of heterogeneity by Ethnicity and quality of studies. Results showed that ethnicity contribute to substantial heterogeneity. Furthermore, we performed sensitivity analyses to assess the influence of each individual study on the pooled ORs by sequential omission of individual studies, such as the study that did not conform to HWE. However, the corresponding pooled ORs were not materially altered by removing any individual study. Moreover, in all tests the I 2 value for heterogeneity did not reduced. Therefore, the sensitivity analysis confirmed that the results of this meta-analysis were statistically reliable and stable. 
Study name
Publication bias
Begg's funnel plot and Egger's test were used to assess the potential publication bias in the literature. However, the shape of funnel plots did not reveal any evidence of funnel plot asymmetry (FIGURE 2A, 2B) . Then, the Egger's test was used to provide statistical evidence for funnel plot symmetry. The results also provided statistical evidence for the absence of publication bias.
DISCUSSION
To date, several case-control studies have been reported to evaluate the association between IL-10 -1082 A/G polymorphism and gastric cancer. However, the results were inconsistent and most studies in Caucasian and Latinos populations failed to identify an association with gastric cancer. The current study was not the first 
Study name
meta-analysis aimed to evaluate the associations between IL-10 -1082 A/G polymorphism and gastric cancer. However, the current meta-analysis was the most comprehensive assessment of the association between IL-10 -1082 A/G polymorphism and gastric cancer, which extended the previous meta-analyses with a larger sample size and different subgroups. Additionally, we believe the current meta-analysis is most accurate meta-analysis on the association due to the subgroup analysis by studies quality according to the Hardy-Weinberg equilibrium (HWE) status. A total of 30 studies with a total of 6431 controls and 3631 cases were eligible for the meta-analysis of IL-10 -1082 A/G polymorphism and gastric cancer. In this meta-analysis, a significant association of the of IL-10 -1082 A/G polymorphism with gastric cancer risk was found under the allele model (G We found that the results of our meta-analysis are consistent with a meta-analysis of 20 case-control studies with a total of 3631 cases and 6431 controls published in 2012 by Ni et al. to examine the relationship between IL-10 -1082 A/G polymorphism and gastric cancer (17) . They have found that the IL-10 -1082 A/G polymorphism was associated with susceptibility to gastric cancer infection in Asians. However, their study had some limitations should be mentioned. First, they wrongly not included a study by Bai et al., 2008 because they reported only the number of combined group GG+GA rather than the number of genotype GG and GA. Second, they have excluded all studies that deviated from HWE, which it seems publication bias have been occurred at the start of their meta-analysis. However, meta-analyses should report both the magnitude and the statistical significance of deviation from HWE (40) . There is currently no consensus for whether to select eligible studies according to HWE status. In the current metaanalysis the results was different by HWE status or studies quality, it is suggested that the analysis with studies departed from HWE may be more reliable. Third, they have performed some subgroup analyses by sample size and publication before or after 2005, which we suggested unnecessary to do these subgroup analyses. Fourth, their results reliability and the number of studies are considerably smaller than that needed to receive the robust conclusions.
Between-study heterogeneity is inevitable in a meta-analysis (55) . Thus, one of the most important goals of the meta-analysis is to identify the source of heterogeneity (56) . Basically, between-studies variability and variability due to sampling error are main sources of heterogeneity in a set of studies in a meta-analysis (19, 31, 55, 56) . The between-study heterogeneity in the current meta-analysis existed in overall under all genetic models and subgroup analyses in Asians. There was no significant heterogeneity after subgroup analyses among Caucasians and Latinos population. Moreover, after removing the study deviating from HWE, the heterogeneity did not disappear. Thus, the results revealed that studies in Asians may be the major source of heterogeneity in overall models.
The current meta-analysis had several strengths. Most importantly, this is the biggest and most recent meta-analysis of the association between IL-10 -1082 A/G polymorphism and gastric cancer. Therefore, this was more powerful than previous metaanalysis. In addition, a subgroup analysis among mixed population and HWE status was conducted and demonstrated that the IL-10 -1082 A/G polymorphism not significantly associated with gastric cancer risk in Caucasian and mixed populations. Third, we did not detect any publication bias indicating that the whole pooled results should be unbiased.
Despite the clear strength of our study including large sample sizes, some limitations of this meta-analysis should be acknowledged. Second, the overall OR was based on individual unadjusted ORs, and some important confounding factors, such as age, gender, dietary, Helicobacter pylori (H. pylori) infection, tobacco smoking, and alcohol consumption, gastric cancer site (cardia and noncardia) and histological type must be adjusted for. Third, although the funnel plots and Egger's tests showed that publication bias did not affect our results, only published studies published in English or Chinese with sufficient data were included, thus, publication bias may have occurred at the start of current meta-analysis. Finally, lack of original data from origin data in the including studies limited our evaluation of potential gene-gene and gene-environment interactions and even different polymorphic loci of the same gene which may modulate the gastric cancer susceptibility.
In conclusion, this meta-analysis suggests that IL-10 -1082 A/G (rs1800896) polymorphism may be associated with increased gastric cancer risk. Moreover, further studies estimating the effect of gene-gene and gene-environment interactions are necessary to better understanding of the association between the IL-10 -1082 A/G (rs1800896) polymorphism and risk of gastric cancer.
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